Nanotherapeutics, Inc.

Nanotherapeutics, Inc. (“Nanotherapeutics”), a Florida Corporation, has made new discoveries in the area of nanotechnology and is applying them to the development of novel drug therapies.
Nanotherapeutics has developed two proprietary drug delivery technologies, NanodryTM and NanocoatTM, which produce improved pharmaceuticals at high yield that are substantially more versatile and cost-effective than current technologies.
Nanotherapeutic’s technologies focus on making injectable, nasal, and inhaled pharmaceutical products more effective and more patient friendly.

Activity:

- Contract Manufacturing
- Contract Research
- Licensing & Business Development
- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- Devices
- Drug delivery
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Proteins

Therapeutic targets:

- Allergy
- Arthritis / Rheumato
- Asthma
- Cancer
- Central nervous system
- Cough / Cold
- Diabetes
- Infectious Diseases
- Orthopedics
- Pain
- Respiratory Medicine
- Urology

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America

c. Countries active: US

Corporate data:

Number of Employees: 7

Turnover:

Amount:	Year:	Currency:
300000	2001	US Dollar

Year founded: 1999

Partners / Alliances: University of Florida Engineering Research Center
Naval Research Laboratories
NASA Johnson Space Center
NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH National Institute of Allergy and Infectious Diseases (NIAID)
GlaxoSmithKline / GlaxoWellcome Research and Development (UK)
AstraZeneca Research and Development
Bespak Drug Delivery Technologies
Respirics, Inc.
Ixion Biotechnology
Ocean Optics